Valid database instead of paper mess
Manufacturing Execution Systems (MES) have become almost indispensable for the pharmaceutical and biotechnology industry. Complex manufacturer standards and regulations concerning product quality and safety force companies to replace their conventional paper-based documentation and approval processes, which are prone to error. “An MES digitizes these processes so that they are easier to record and document in a legally-compliant manner,” says Völlinger. Moreover, the MES serves as an overarching solution that controls, monitors, and synchronizes production in real time. “It enables companies to collect huge amounts of data from their production operations. This information can be used to analyze many processes and make them more efficient,” says Völlinger. However, many different factors must be considered in the selection and integration of such a control system. For example, it must be determined which MES best fulfills the individual requirements, which system is future proof to the greatest extent, and how the associated change processes can be implemented so that all process areas are taken into account and all employees are involved. Moreover, the background of digitization raises additional questions, such as the use of cloud solutions, MES as a service (MES aaS), agile project development, and the validation of these approaches for Pharma 4.0. The consulting experts from the Körber Business Area Pharma also answer these complex questions for their customers.